Nuclear Receptors and Inflammatory Diseases
- 1 May 2008
- journal article
- review article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 233 (5), 496-506
- https://doi.org/10.3181/0708-mr-231
Abstract
It is well known that the steroid hormone glucocorticoid and its nuclear receptor regulate the inflammatory process, a crucial component in the pathophysiological process related to human diseases that include atherosclerosis, obesity and type II diabetes, inflammatory bowel disease, Alzheimer’s disease, multiple sclerosis, and liver tumors. Growing evidence demonstrates that orphan and adopted orphan nuclear receptors, such as peroxisome proliferator-activated receptors, liver x receptors, the farnesoid x receptor, NR4As, retinoid x receptors, and the pregnane x receptor, regulate the inflammatory and metabolic profiles in a ligand-dependent or -independent manner in human and animal models. This review summarizes the regulatory roles of these nuclear receptors in the inflammatory process and the underlying mechanisms.Keywords
This publication has 145 references indexed in Scilit:
- Effects of FXR in foam-cell formation and atherosclerosis developmentBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2006
- General Principles and Pharmacology of Biologics in Inflammatory Bowel DiseaseGastroenterology Clinics of North America, 2006
- PPAR as a new therapeutic target in inflammatory bowel diseasesGut, 2006
- Mutual repression between steroid and xenobiotic receptor and NF- B signaling pathways links xenobiotic metabolism and inflammationJCI Insight, 2006
- Inhibition of Carrageenan-Induced Cutaneous Inflammation by PPAR Agonists Is Dependent on Hepatocyte-Specific Retinoid X ReceptorAlphaPPAR Research, 2006
- PPARα activation abolishes LDL-stimulated IL-8 production via AP-1 deactivation in human aortic smooth muscle cellsBiochemical and Biophysical Research Communications, 2004
- Expression of cytochrome P450 4A mRNA in mouse lung: effect of clofibrate and interleukin‐1βFundamental & Clinical Pharmacology, 2004
- Control of Vascular Cell Proliferation and Migration by PPAR-γDiabetes Care, 2001
- Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator–activated receptor γJCI Insight, 2000
- Activation of PPARα or γ Reduces Secretion of Matrix Metalloproteinase 9 but Not Interleukin 8 from Human Monocytic THP-1 CellsBiochemical and Biophysical Research Communications, 2000